Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
0.3890
+0.0170 (4.57%)
Apr 24, 2025, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $14.91 million as of April 24, 2025. Its market cap has decreased by -71.45% in one year.
Market Cap
14.91M
Enterprise Value
-7.20M
1-Year Change
-71.45%
Ranking
Category
Stock Price
$0.39
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $14.91M, a decrease of -97.84%. That is a compound annual growth rate of -59.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 14.26M | -30.36% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 743.12B |
| UnitedHealth Group | 388.83B |
| Johnson & Johnson | 380.15B |
| AbbVie | 307.25B |
| Novo Nordisk | 266.18B |
| Abbott Laboratories | 228.46B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |